Specific protection against breast cancers by cyclin D1 ablation (original) (raw)

• Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999).
  Article CAS Google Scholar
• Dickson, C. et al. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett. 90, 43–50 (1995).
  Article CAS Google Scholar
• Bartkova, J. et al. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57, 353–361 (1994).
  Article CAS Google Scholar
• Gillett, C. et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54, 1812–1817 (1994).
  CAS PubMed Google Scholar
• McIntosh, G. G. et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 11, 885–891 (1995).
  CAS PubMed Google Scholar
• Weinstat-Saslow, D. et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1, 1257–1260 (1995).
  Article CAS Google Scholar
• Gillett, C. et al. Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer 69, 92–99 (1996).
  Article CAS Google Scholar
• Wang, T. C. et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369, 669–671 (1994).
  Article ADS CAS Google Scholar
• Sicinski, P. et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621–630 (1995).
  Article CAS Google Scholar
• Fantl, V., Stamp, G., Andrews, A., Rosewell, I. & Dickson, C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9, 2364–2372 (1995).
  Article CAS Google Scholar
• Sinn, E. et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49, 465–475 (1987).
  Article CAS Google Scholar
• Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R. & Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54, 105–115 (1988).
  Article CAS Google Scholar
• Stewart, T. A., Pattengale, P. K. & Leder, P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38, 627–637 (1984).
  Article CAS Google Scholar
• Tsukamoto, A. S., Grosschedl, R., Guzman, R. C., Parslow, T. & Varmus, H. E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55, 619–625 (1988).
  Article CAS Google Scholar
• Rimerman, R. A., Gellert-Randleman, A. & Diehl, J. A. Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation. J. Biol. Chem. 275, 14736–14742 (2000).
  Article CAS Google Scholar
• Tetsu, O. & McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422–426 (1999).
  Article ADS CAS Google Scholar
• Sicinski, P. et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384, 470–474 (1996).
  Article ADS CAS Google Scholar
• Ball, R. K., Friis, R. R., Schoenenberger, C. A., Doppler, W. & Groner, B. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 7, 2089–2095 (1988).
  Article CAS Google Scholar
• Lukas, J. et al. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene 10, 2125–2134 (1995).
  CAS PubMed Google Scholar
• Janes, P. W., Daly, R. J., de Fazio, A. & Sutherland, R. L. Activation of the Ras signaling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9, 3601–3608 (1994).
  CAS PubMed Google Scholar
• Filmus, J. et al. Induction of Cyclin D1 overexpression by activated ras. Oncogene 9, 3627–3633 (1994).
  CAS Google Scholar
• Albanese, C. et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589–23597 (1995).
  Article CAS Google Scholar
• Liu, J. J. et al. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15, 3654–3663 (1995).
  Article CAS Google Scholar
• Lavoie, J. N., L’Allemain, G., Brunet, A., Mueller, R. & Pouyssegur, J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608–20616 (1996).
  Article CAS Google Scholar
• Lee, R. J. et al. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol. Cell. Biol. 20, 672–683 (2000).
  Article CAS Google Scholar
• Geng, Y. et al. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 97, 767–777 (1999).
  Article CAS Google Scholar
• Alevizopoulos, K., Vlach, J., Hennecke, S. & Amati, B. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16, 5322–5333 (1997).
  Article CAS Google Scholar
• Santoni-Rugiu, E., Falck, J., Mailand, N., Bartek, J. & Lukas, J. Involvement of Myc activity in a G1/S-promoting mechanism parallel to the pRb/E2F pathway. Mol. Cell. Biol. 20, 3497–3509 (2000).
  Article CAS Google Scholar
• Robles, A. I. et al. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev. 12, 2469–2474 (1998).
  Article CAS Google Scholar
• Bieche, I. & Lidereau, R. Genetic alterations in breast cancer. Genes Chromosom. Cancer 14, 227–251 (1995).
  Article CAS Google Scholar
• Bargmann, C. I., Hung, M. C. & Weinberg, R. A. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45, 649–657 (1986).
  Article CAS Google Scholar